User Fee Exemption From Sequester Could Take Flight
This article was originally published in The Gray Sheet
Executive Summary
A bipartisan group of House appropriations committee members criticized the current policy of FDA user fee revenue being captured by the mandatory budget cuts.
You may also be interested in...
House Plan Includes No Increase For CDRH In 2014; User Fee Sequester Unresolved
A House subcommittee passed an appropriations package last week that would keep FDA device funding levels flat in fiscal 2014. The package would increase appropriations to FDA as a whole compared to 2013, but it falls short of the President’s budget request, and leaves unresolved whether 2014 user fees would be sequestered.
CDRH Sequestration Impact: Training, Standards And Reg Science
CDRH Director Jeffrey Shuren detailed last week how federal sequestration cuts to FDA are impacting specific device center programs, including training, standards development and regulatory science. Shuren also signaled imminent policy releases from the center, including a finalized post-market surveillance plan.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.